Paradigm Biopharmaceuticals (ASX:PAR) - Webinar Presentation Company Presentations by Finance News Network October 13, 2023 04:42 PM Email Alerts for: ASX:PAR Paul Rennie - Founder and Managing Director - Paradigm Biopharmaceuticals Limited (ASX:PAR) is a global biopharmaceutical company. Its current focus is a drug for the treatment of osteoarthritis.
